Professor of Internal Medicine

42
Liver cirrhosis Liver cirrhosis Usama Ahmed Arafa, MD Usama Ahmed Arafa, MD Professor of Internal Medicine Professor of Internal Medicine

Transcript of Professor of Internal Medicine

Page 1: Professor of Internal Medicine

Liver cirrhosisLiver cirrhosis

Usama Ahmed Arafa, MDUsama Ahmed Arafa, MD

Professor of Internal MedicineProfessor of Internal Medicine

Page 2: Professor of Internal Medicine

Definition

Page 3: Professor of Internal Medicine

Liver cirrhosis is characterized by:Liver cirrhosis is characterized by:

11-- Hepatocellular necrosisHepatocellular necrosis

22-- Hepatic fibrosisHepatic fibrosis22-- Hepatic fibrosisHepatic fibrosis

33-- Regeneration nodulesRegeneration nodules

44-- Loss of architectureLoss of architecture

Page 4: Professor of Internal Medicine

Normal Liver

Page 5: Professor of Internal Medicine

Cirrhosis

Page 6: Professor of Internal Medicine

Normal Liver Histology

CV

PT

Page 7: Professor of Internal Medicine

Cirrhosis

Fibrosis

Regenerating Nodule

Page 8: Professor of Internal Medicine

Etiology

Page 9: Professor of Internal Medicine

Common causesCommon causes

•• Chronic viral hepatitis: C, B Chronic viral hepatitis: C, B ±± DD•• AlcoholAlcohol•• SchistosomiasisSchistosomiasis (fibrosis not true LC)(fibrosis not true LC)

Less Common causesLess Common causesLess Common causesLess Common causes

•• Biliary cirrhosis: Biliary cirrhosis: -- primary primary -- secondarysecondary•• Autoimmune hepatitis Autoimmune hepatitis •• Hereditary: Hereditary: -- HaemochromatosisHaemochromatosis -- Wilson's Wilson's

disease disease -- Alpha Alpha 1 1 antitrypsin deficiencyantitrypsin deficiency

Page 10: Professor of Internal Medicine

•• Drugs (e.g. methotrexate) Drugs (e.g. methotrexate) •• Cystic fibrosis Cystic fibrosis •• NonNon--alcoholic fatty liver disease alcoholic fatty liver disease

(NAFLD) (NAFLD) •• Glycogen storage diseaseGlycogen storage disease•• Glycogen storage diseaseGlycogen storage disease•• VenoVeno--occlusive disease occlusive disease •• Hepatic venous congestion Hepatic venous congestion •• BuddBudd--Chiari syndrome Chiari syndrome •• Idiopathic (cryptogenic)Idiopathic (cryptogenic)

Page 11: Professor of Internal Medicine

Pathogenesis

Page 12: Professor of Internal Medicine

•• Chronic injury to the liver results in Chronic injury to the liver results in inflammation, necrosis and, eventually, inflammation, necrosis and, eventually, fibrosis. fibrosis.

•• Fibrosis is initiated by activation of the Fibrosis is initiated by activation of the stellate cells.stellate cells.

Page 13: Professor of Internal Medicine

•• In the space of In the space of DisseDisse, the normal matrix is , the normal matrix is replaced by collagen. replaced by collagen. SubendothelialSubendothelial fibrosis fibrosis leads to loss of the endothelial fenestrations, leads to loss of the endothelial fenestrations, and this impairs liver function.and this impairs liver function.

•• There is accumulating evidence that liver There is accumulating evidence that liver fibrosis is reversible.fibrosis is reversible.

Page 14: Professor of Internal Medicine

•• Pathogenesis of fibrosis Pathogenesis of fibrosis

Page 15: Professor of Internal Medicine

Pathological Types

Page 16: Professor of Internal Medicine

Micronodular cirrhosisMicronodular cirrhosis:: Regenerating nodules Regenerating nodules

are usually less than are usually less than 3 3 mm in size. This type is mm in size. This type is often caused by alcoholic or biliary cirrhosis.often caused by alcoholic or biliary cirrhosis.

Macronodular cirrhosisMacronodular cirrhosis:: The nodules are of The nodules are of Macronodular cirrhosisMacronodular cirrhosis:: The nodules are of The nodules are of

variable size and normal acini may be seen within variable size and normal acini may be seen within the larger nodules. This type is often seen the larger nodules. This type is often seen following previous hepatitis.following previous hepatitis.

A mixed picture:A mixed picture: with small and large nodules is with small and large nodules is

sometimes seen.sometimes seen.

Page 17: Professor of Internal Medicine

Micronodular cirrhosis

Page 18: Professor of Internal Medicine

Micronodular cirrhosis:

Page 19: Professor of Internal Medicine

Macronodular Cirrhosis

Page 20: Professor of Internal Medicine

Symptoms and Signs

Page 21: Professor of Internal Medicine

AA-- General manifestationsGeneral manifestations

•• WastingWasting

•• Parotid enlargementParotid enlargement•• Parotid enlargementParotid enlargement

•• Hyperkinetic circulationHyperkinetic circulation

•• Increased susceptibility to infectionIncreased susceptibility to infection

Page 22: Professor of Internal Medicine

BB-- Skin Skin manifestationsmanifestations

•• Spider Spider angiomataangiomata

•• Palmar erythemaPalmar erythema

•• LeuconychiaLeuconychia•• LeuconychiaLeuconychia

•• DupuytrenDupuytren’’ss contracturescontractures

•• XanthomasXanthomas

•• Alternation of body hair distributionAlternation of body hair distribution

Page 23: Professor of Internal Medicine

CC-- Endocrinal Endocrinal manifestationsmanifestations

•• GynecomastiaGynecomastia

•• Testicular atrophyTesticular atrophy

•• Amenorrhea in femalesAmenorrhea in females•• Amenorrhea in femalesAmenorrhea in females

Page 24: Professor of Internal Medicine

GynecomastiaGynecomastia in cirrhosisin cirrhosis

Page 25: Professor of Internal Medicine

DD-- Abdominal Abdominal manifestationsmanifestations

•• Hepatomegaly then shrinkage laterHepatomegaly then shrinkage later

•• SplenomegalySplenomegaly

•• Prominent abdominal veinsProminent abdominal veins•• Prominent abdominal veinsProminent abdominal veins

•• Peptic ulcer diseasePeptic ulcer disease

•• Chronic pancreatitisChronic pancreatitis

•• SteatorrheaSteatorrhea

Page 26: Professor of Internal Medicine

PortosystemicPortosystemic anastomosis: anastomosis: Prominent abdominal veins.Prominent abdominal veins.

Page 27: Professor of Internal Medicine

EE-- DecompensationDecompensation

•• JaundiceJaundice

•• AscitisAscitis

•• Bleeding tendencyBleeding tendency•• Bleeding tendencyBleeding tendency

•• Hepatic encephalopathyHepatic encephalopathy

Page 28: Professor of Internal Medicine

Physical signs in liver cirrhosis.

Page 29: Professor of Internal Medicine

InvestigationsInvestigations

Page 30: Professor of Internal Medicine

Investigations for severityInvestigations for severity

Liver function. Liver function. Serum albumin and prothrombin Serum albumin and prothrombin time are the best indicators of liver function. time are the best indicators of liver function.

■■ Liver biochemistry. Liver biochemistry. In most cases there is a slight In most cases there is a slight ■■ Liver biochemistry. Liver biochemistry. In most cases there is a slight In most cases there is a slight elevation in the serum ALP and serum elevation in the serum ALP and serum aminotransferases.aminotransferases.

■■ Serum electrolytes. Serum electrolytes. A low sodium indicates severeA low sodium indicates severe

liver disease.liver disease.

Page 31: Professor of Internal Medicine

Investigations for the etiologyInvestigations for the etiology

•• Viral markers Viral markers

•• Serum autoantibodies Serum autoantibodies

•• Iron indices and ferritin Iron indices and ferritin

•••• Iron indices and ferritin Iron indices and ferritin

•• Copper, ceruloplasmin Copper, ceruloplasmin

•• AlphaAlpha1 1 antitrypsin antitrypsin

(Serum copper and alpha(Serum copper and alpha1 1 antitrypsin should always beantitrypsin should always be

measured in young cirrhotics)measured in young cirrhotics)

Page 32: Professor of Internal Medicine

OthersOthers

•• Ultrasound examination.Ultrasound examination.

•• CT scan.CT scan.

•••• MRI scan.MRI scan.

•• Endoscopy.Endoscopy.

•• Liver biopsy.Liver biopsy.

Page 33: Professor of Internal Medicine

Management

Page 34: Professor of Internal Medicine

►►Management is that of complications. Management is that of complications.

►►Patients should have Patients should have 66--monthly monthly ultrasound and serum AFP to detect the ultrasound and serum AFP to detect the development of a hepatocellular development of a hepatocellular carcinoma as early as possible.carcinoma as early as possible.carcinoma as early as possible.carcinoma as early as possible.

►►There is no treatment that will arrest or There is no treatment that will arrest or reverse the cirrhotic changes although reverse the cirrhotic changes although progression may be halted by correcting progression may be halted by correcting the underlying cause.the underlying cause.

Page 35: Professor of Internal Medicine

►►Patients with compensated cirrhosis Patients with compensated cirrhosis should lead a normal life. should lead a normal life.

►►The only dietary restriction is to reduce The only dietary restriction is to reduce salt intake. salt intake.

►►Aspirin and NSAIDs should be avoided.Aspirin and NSAIDs should be avoided.

►►Alcohol should be avoided.Alcohol should be avoided.

Page 36: Professor of Internal Medicine

LIVER TRANSPLANTATIONLIVER TRANSPLANTATION

►►This is an established treatment for aThis is an established treatment for anumber of liver diseases. number of liver diseases.

►►Shortage of donors is a major problem Shortage of donors is a major problem in all developed countries.in all developed countries.

Page 37: Professor of Internal Medicine

Course and PrognosisCourse and Prognosis

Page 38: Professor of Internal Medicine

Child's-Pugh classification

Score 1 2 3• Ascites None Mild Moderate/severe

• Encephalopathy None Mild Marked

• Bilirubin < 2 mg/dL 2-3 >3

• Albumin > 3.5 (g/dL) 3.5-2.8 < 2.8

• Prothrombin time < 4 seconds 4-6 > 6• Prothrombin time < 4 seconds 4-6 > 6

(Scores) 1-year survival 5 years 10 years

Child's A (< 7) 82 45 25

Child's B (7-9) 62 20 7

Child's C (10+) 42 20 0

Page 39: Professor of Internal Medicine

COMPLICATIONS AND EFFECTS OF CIRRHOSISOF CIRRHOSIS

Page 40: Professor of Internal Medicine

►►Portal hypertension and gastrointestinal Portal hypertension and gastrointestinal haemorrhagehaemorrhage

►►AscitesAscites

►►PortosystemicPortosystemic encephalopathyencephalopathy

►►Renal failure (Renal failure (hepatorenalhepatorenal syndrome)syndrome)►►Renal failure (Renal failure (hepatorenalhepatorenal syndrome)syndrome)

►►HepatopulmonaryHepatopulmonary syndromesyndrome

►►Hepatocellular carcinomaHepatocellular carcinoma

►►BacteraemiasBacteraemias, , infectionsinfections

►►MalnutritionMalnutrition

Page 41: Professor of Internal Medicine

Ascites in Cirrhosis

Page 42: Professor of Internal Medicine

Hepatocellular Carcinoma